Investor Presentation Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investor Presentation for Q3FY25
Investor Presentation Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investor Presentation for Q2FY25
Investor Presentation Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Presentation for the information of Investors
Investor Presentation Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Presentation at 20th Annual Global Investor Conference Organized by Motilal Ostwal
Investor Presentation Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Presentation at 20th Annual Global Investor Conference Organized by Motilal Ostwal
Investor Presentation Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investor Presentation on Financial Results of the Company for the quarter ended on June 30, 2024.
Investor Presentation Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investor Presentation on Mankind Pharma to acquire 100% stake in BSV
Investor Presentation Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investor Presentation for the quarter and financial year ended 31st March 2024.
Investor Presentation Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investor Presentation on Financial Results of Q3 FY24
Investor Presentation Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Presentation at 42nd Annual JP Morgan Healthcare Conference